Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Suzhou Hightechbio Biotechnology is a specialized biotechnology company and contract research organization (CRO) located in the Suzhou Industrial Park, China. The company focuses on the discovery and development of drugs targeting membrane proteins, with a particular emphasis on G protein-coupled receptors (GPCRs) and ion channels. They provide a range of services including high-throughput screening, automated patch-clamp electrophysiology, and the development of functional cell-based assays. By utilizing state-of-the-art technology platforms such as FLIPR and automated electrophysiology systems, Hightechbio assists global partners in accelerating their drug discovery pipelines for neurological, cardiovascular, and metabolic diseases. In addition to its service offerings, the company maintains internal research programs aimed at identifying novel modulators for high-value therapeutic targets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Suzhou Hightechbio Biotechnology.